| • |
|
Safety and Sustainability: |
| |
|
|
| |
- |
Continued high safety performance with a 12-month moving average Lost Time Injury Frequency Rate of 1.1. |
| |
|
|
| • |
|
Production: |
| |
|
|
| |
- |
Record half year combined production of 4.120Mlb U3O8, an increase of 34% on the December 2011 half year achieving 97% of nameplate production of 4.250Mlb U3O8 for the half year. December 2012 half year affected by a 16-day planned annual maintenance shutdown at Kayelekera. |
| |
|
|
| |
- |
Record quarterly combined production of 2.191Mlb U3O8, an increase of 14% on the September 2012 quarter, achieving 103% of nameplate production of 2.125Mlb U3O8 for the quarter. |
| |
|
|
| |
- |
Total annual production for CY2012 of 7.946Mlb U3O8, a 34% increase over the previous calendar year. |
| |
|
|
| • |
|
Langer Heinrich Mine: |
| |
|
|
| |
- |
Record half year production of 2.709Mlb U3O8, an increase of 33% over the half year ended 31 December 2011 achieving 104% of nameplate design capacity. |
| |
|
|
| |
- |
Record quarterly production of 1.419Mlb U3O8, an increase of 10% over the September 2012 quarter achieving 109% of nameplate design capacity. |
| |
|
|
| |
- |
Ability to produce at nameplate with feed grades below design demonstrated. |
| |
|
|
| |
- |
Record quarterly recovery of 87.4% compared to design of 85%. |
| |
|
|
| • |
|
Kayelekera Mine: |
| |
|
|
| |
- |
Half year production of 1.411Mlb U3O8, an increase of 37% over the half year ended 31 December 2011, achieving 85% of nameplate design capacity. |
| |
|
|
| |
- |
Record quarterly production of 0.772Mlb U3O8, an increase of 21% over the September 2012 quarter, achieving 94% of nameplate design capacity. Remaining constraints of resin-in-pulp (RIP)/elution circuits are being addressed. |
| |
|
|
| |
- |
Maintaining improved acid plant production as a result of upgrades during the shutdown, which continue to provide positive cost implications with reduced dependence on imported acid. |
| |
|
|
| |
- |
Benefits of process optimisation continue to be realised. |
| |
|
|
| • |
|
Impairment: |
| |
|
|
| |
- |
Due to continued uranium price weakness, an impairment expense of US$54.9M has been recorded at Kayelekera for the December quarter, totalling US$96.0M for the half year. |
| |
|
|
| • |
|
Completion Tests: |
| |
|
|
| |
- |
The CT under both the Langer Heinrich Mine project finance facility and the Kayelekera Mine project finance facility have been satisfied which will result in a reduction in interest charges and provide greater flexibility with regards to voluntary prepayments and distributions under both facility agreements. |
| |
|
|
| • |
|
Sales: |
| |
|
|
| |
- |
Sales revenue increased 13% from US$172.7M in 2011 to US$194.9M for the six months ended December 2012, as a result of higher sales volumes. The average realised uranium price for the six months was US$48.63/lb U3O8 (2011: US$52.00/lb). The average UxC spot price for the six months was US$45.95/lb. |
| |
|
|
| |
- |
Total sales volume for the six months of 4.008Mlb U3O8 - a 21% increase over the December 2011 half year sales of 3.320Mlb U3O8. |
| |
|
|
| |
- |
Uranium sales volumes are expected to fluctuate quarter-on-quarter due to the uneven timing of contractual commitments and resultant scheduling by customers. Now that production has reached design levels, sales and production volumes are expected to be comparable on an annualised basis. |
| |
|
|
| • |
|
C1 Cost of Production: |
| |
|
|
| |
- |
Langer Heinrich C1 cost of production for the quarter decreased 7.0% to US$29.60/lb U3O8 from US$31.80/lb U3O8 in the September 2012 quarter, mainly due to the cost benefits of the increased Stage 3 production and the weakening of the Namibian dollar against the United States dollar. |
| |
|
|
| |
- |
Kayelekera C1 cost of production for the quarter decreased 11.3% to US$43.50/lb from US$49.00/lb in the September 2012 quarter, highlighting that the cost benefits from the cost optimisation programme at Kayelekera continued to be realised. Cost optimisation continues to be a key focus, with specific target areas including mining, acid, reagents, diesel, transport and staff rationalisation. Major benefits from these cost reductions and production optimisation efforts are expected over the next 18 months. |
| |
|
|
| |
|
(1)C1 Cost of production = cost of production excluding product distribution costs, sales royalties and depreciation and amortisation before adjustment for impairment.C1 cost, which is non-IFRS information, is a widely used 'industry standard' term. |
| |
|
|
| • |
|
Cost Reduction/Production Optimisation Initiative: |
| |
|
|
| |
- |
Following both operations reaching nameplate performance, the sites are now entering a period of optimisation, which will lead to improved process recoveries and reduced unit operating costs. Some elements of this work have the potential to expand the reserve base for both projects by being able to use lower ROM feed grades. |
| |
|
|
| |
- |
In November 2012, the Company announced its programme to reduce costs within the Group, which is expected to realise US$60M to US$80M total savings over the next two years. The comprehensive cost and production optimisation review is part of the process of moving from development to a sustained production phase. The cost review encompassed examination of all activities within the Paladin Group from its mining operations, corporate/administration overheads, future development considerations, exploration, sales and business development. Opportunity for re-negotiation of key mining and consumables contracts has arisen, paving the way for material cost reductions over the next two years. |
| |
|
|
| |
- |
In terms of cost savings the Company is targeting a 7.5% reduction in unit cash costs for the remainder of FY2013 at both Langer Heinrich and Kayelekera and, for FY2014, is targeting a further 7.5% reduction at Langer Heinrich and 15% at Kayelekera. For the remainder of FY2013 exploration will be scaled back by 20% (US$4.0M) of budget, mainly through deferring non-essential drilling and corporate overheads, which are targeted to be reduced by 10% (US$3M). |
| |
|
|
| |
- |
The Company remains focused on reducing costs across all facets of the business and work continues to identify more cost saving opportunities. |
| |
|
|
| • |
|
Profit and Loss: |
| |
|
|